Douglas to keep it in the family after considering bids
This article was originally published in Scrip
Executive Summary
Companies looking to expand their presence in New Zealand through acquisitions can strike off their lists of prospects the most obvious target - the country's largest home-grown pharma firm, Douglas Pharmaceuticals.